Growth Equity

A new AIAA report outlines the top ten technologies, from AI to hypersonics, set to revolutionize air travel and space exploration by 2045.

A $3M grant from Lilly Endowment will empower Hope For The Warriors to expand evidence-based care and secure its future for military families nationwide.

The latest astronaut crew on the ISS is conducting cutting-edge research in microgravity, aiming to revolutionize healthcare and environmental tech on Earth.

Lucerne Capital Management appoints veteran Frank Austin to head its new U.S. farmland strategy, signaling a deeper Wall Street move into agriculture.

Ahead of final investment decision, NMG awards contracts covering over 50% of CAPEX, solidifying its path to supply North America's EV battery market.

Carnelian Energy Capital funds Azul Resources II, reuniting a successful team to tap the Haynesville Shale, betting big on LNG export demand.

O'Leary Digital unveils a colossal 15-gigawatt plan for AI data centers in Utah and Alberta, but faces environmental backlash and Indigenous opposition.

UK brand Aurelia Cellular Vitality launches in the US, betting its science-led Eternacell™ complex can disrupt the booming ingestible beauty industry.

NRx Pharmaceuticals gets a green light from the FDA to seek broader approval for its ketamine drug, NRX-100, using a novel real-world evidence approach.

With 13,000 attendees and a bold expansion to Ras Al Khaimah, AIBC Eurasia 2026 highlights a major shift of tech's center of power to the East.

With its expansion to Europe and LATAM, Halper AI and its founder are betting on a radical idea: the best AI is the one you never have to open.

Investors eye Globus Medical's upcoming report for a full-year look at its NuVasive integration, market trends, and a pivotal 2025 performance.

As Yellowknife faces a dire housing shortage and rising homelessness, all eyes are on a major federal-territorial announcement. Will it be a lifeline?

The executive compensation firm appoints a new leader with a PE-backed growth record, signaling a strategic push into technology and expanded services.

With $255M from star investors, a firm is betting on a radical idea: that treating employees with dignity is the best way to generate returns.

Gloo's major sponsorship of NRB 2026 signals a new era of AI in faith, but raises critical questions about technology's role in modern spirituality.

With co-founder Tony Ngai now Co-President and CTO, Efinix is scaling its unique FPGA technology to capture the explosive demand in the edge AI market.

A new partnership merges AI speed with human expertise, aiming to redefine corporate due diligence and risk management in an increasingly volatile world.

A new report shows the carbon removal market has the tools to fight climate change, but widespread corporate inaction threatens to strand vital projects.

Belgian biotech Agomab Therapeutics secures $200 million in its Nasdaq debut, fueling its mission to develop therapies for debilitating fibrotic conditions.